ARTV
Artiva Biotherapeutics, Inc.
8.40$
-1.9%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Artiva Biotherapeutics, Inc. (ARTV) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/11/2026 | Current report (8-K) | Artiva Biotherapeutics, Inc. (ARTV): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View report ↗ |
| 08/06/2026 | Current report (8-K) | Artiva Biotherapeutics, Inc. (ARTV): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/22/2026 | Current report (8-K) | Artiva Biotherapeutics, Inc. (ARTV): Other Events | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.